Single vs Repeated Treatment with the Intragastric Balloon: A 5-Year Weight Loss Study

被引:42
作者
Dumonceau, Jean-Marc [1 ,2 ]
Francois, Erik [3 ]
Hittelet, Axel [3 ]
Mehdi, Abdel Ilah [4 ]
Barea, Marie [3 ]
Deviere, Jacques [3 ]
机构
[1] Univ Hosp Geneva, Div Gastroenterol & Hepatol, CH-1205 Geneva, Switzerland
[2] Univ Hosp Geneva, Serv Gastroenterol & Hepatol, CH-1205 Geneva, Switzerland
[3] Erasme Univ Hosp, Dept Gastroenterol & Hepatopancreatol, B-1070 Brussels, Belgium
[4] Erasme Univ Hosp, Dept Digest Surg, B-1070 Brussels, Belgium
关键词
Obesity; Gastrointestinal endoscopy; Gastric balloon; Weight loss; MORBID-OBESITY; TERM; TOLERANCE;
D O I
10.1007/s11695-010-0127-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Saline-filled intragastric balloons (IB) may be inserted for 6 months to promote weight loss. We aimed to assess potential benefits of repeating IB therapy. Methods One hundred eighteen consecutive subjects (median body mass index, 34.0 kg/m(2); interquartile range [IQR], 31.2-36.9) treated with IB were included in a prospective non-randomized multicenter study. Results Nineteen (16%) subjects had repeat IB therapy at their own request, either to prolong first treatment (n=8) or after a IB-free interval (n=11). Higher weight loss 3 months after first IB insertion independently predicted repeat therapy (P=0.008). Median weight loss in subjects who had repeat therapy was lower with second vs first IB (9.0 vs 14.6 kg; 30.4% vs 49.3% excess weight [EW]; P=0.003). Compared to subjects with single treatment (n=99), those with repeat treatment (n=19) had greater weight loss at first IB extraction (14.6 vs 11.0 kg; 49.3% vs 30.7% EW; P=0.026) and 1 year later (12.0 vs 6.0 kg; 40.9% vs 20.8% EW; P=0.008) but the difference became less than 2 kg starting at 3 years. At final follow-up (4.9 years; IQR, 3.4-6.7), the whole subject population had lost a median of 2.0 kg (IQR, -3.0 to 10.3) or 6.2% EW (IQR, -8.1 to 31.6) and identical proportions of subjects with single/repeat treatment had >= 10% baseline weight loss (26%) or bariatric surgery (32%). Conclusion Higher weight loss at 3 months independently predicted repeat IB therapy; weight loss with the second IB was lower compared to first IB. Repeat treatment had no effect on proportions of subjects with >= 10% baseline weight loss or bariatric surgery at final follow-up.
引用
收藏
页码:692 / 697
页数:6
相关论文
共 21 条
[1]  
[Anonymous], 1929, KLIN WOCHENSCHR, DOI DOI 10.1007/BF01738018
[2]   Meta-analysis: The effect of dietary counseling for weight loss [J].
Dansinger, Michael L. ;
Tatsioni, Athina ;
Wong, John B. ;
Chung, Mei ;
Balk, Ethan M. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (01) :41-50
[3]   Treatment of morbid obesity with intragastric balloon in association with diet [J].
Doldi, SB ;
Micheletto, G ;
Perrini, MN ;
Librenti, MC ;
Rella, S .
OBESITY SURGERY, 2002, 12 (04) :583-587
[4]   Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice [J].
Douketis, JD ;
Macie, C ;
Thabane, L ;
Williamson, DF .
INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 (10) :1153-1167
[5]   Evidence-based Review of the Bioenterics Intragastric Balloon for Weight Loss [J].
Dumonceau, Jean-Marc .
OBESITY SURGERY, 2008, 18 (12) :1611-1617
[6]   Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes [J].
Eddy, DM ;
Schlessinger, L ;
Kahn, R .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (04) :251-264
[7]   Intragastric balloon in the treatment of patients with morbid obesity [J].
Evans, JD ;
Scott, MH .
BRITISH JOURNAL OF SURGERY, 2001, 88 (09) :1245-1248
[8]   Ultrasound as the imaging method of choice for monitoring the intragastric balloon in obese patients: Normal findings, pitfalls and diagnosis of complications [J].
Francica, G ;
Giardiello, C ;
Iodice, G ;
Cristiano, S ;
Scarano, F ;
Delle Cave, M ;
Sarrantonio, G ;
Troiano, E .
OBESITY SURGERY, 2004, 14 (06) :833-837
[9]   BioEnterics® Intragastric Balloon (BIB®):: a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients [J].
Genco, A ;
Cipriano, M ;
Bacci, V ;
Cuzzolaro, M ;
Materia, A ;
Raparelli, L ;
Docimo, C ;
Lorenzo, M ;
Basso, N .
INTERNATIONAL JOURNAL OF OBESITY, 2006, 30 (01) :129-133
[10]   What becomes of patients one year after the intragastric balloon has been removed? [J].
Herve, J ;
Wahlen, CH ;
Schaeken, A ;
Dallemagne, B ;
Dewandre, JM ;
Markiewicz, S ;
Monami, B ;
Weerts, J ;
Jehaes, C .
OBESITY SURGERY, 2005, 15 (06) :864-870